Year 2018 / Volume 110 / Number 8
Letter
Sweet syndrome after treatment with vedolizumab in a patient with Crohn’s disease

530

DOI: 10.17235/reed.2018.5603/2018

Blanca Martínez Andrés, Violeta Sastre Lozano, José Francisco Sánchez Melgarejo,

Abstract
Sweet syndrome is a common extraintestinal manifestation in inflammatory bowel disease (IBD). In this research, a 42-year-old man case with colon Crohn's disease is been described. After failure with two anti-TNF therapies, in treatment with azathioprim, it was decided to start a therapeutic target change to Vedolizumab due to a severe outbreak refractory to corticosteroids. 24 hours after the infusion of the new drug, skin lesions appear along with leukocytes with neutrophilia, all suggestive of sweet syndrome later confirmed by histology. In this clinical case, the importance of knowing the possible side effects of recently commercialized drugs for IBD is shown, being this topic important for gastroenterologists due to the wide therapeutic arsenal that is becoming available for this pathology.
Share Button
New comment
Comments
No comments for this article
References
1- Olmedo-Martín RV, Amo-Trillo V, González-Grande R et al. Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis. Rev Esp Enferm Dig 2017;109(9):659-62.
2- Ortega-Alonso A, López-Navarro N, Gallego E et al. Crohn's disease and Sweet's syndrome: A debut together. Rev Esp Enferm Dig. 2015;107(12):765-6.
3- Catalán-Serra I, Martín-Moraleda L, Navarro-López L et al. Crohn's disease and Sweet's syndrome: an uncommon association. Rev Esp Enferm Dig. 2010;102(5):331-7.
Related articles

Letter

Coincidental oral lesions in Crohn’s disease

DOI: 10.17235/reed.2023.9992/2023

Letter

Duodenal stenosis surgical treatment in Crohn’s disease

DOI: 10.17235/reed.2023.9521/2023

Digestive Diseases Image

Peristomal cutaneous Crohn's disease by contiguity

DOI: 10.17235/reed.2022.8909/2022

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Crohn’s disease in patients treated with etanercept

DOI: 10.17235/reed.2019.6554/2019

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Letter to the Editor

Adnexal localization of Crohn’s disease and recurrent massive ovary cysts

DOI: 10.17235/reed.2016.4301/2016

Case Report

Metastatic Crohn’s disease in pediatrics

DOI: 10.17235/reed.2016.3948/2015

Letter to the Editor

Crohn’s disease and Sweet’s syndrome: A debut together

DOI: 10.17235/reed.2015.3842/2015

Case Report

Ovarian involvement in Crohn´s disease: A rare complication

DOI: 10.17235/reed.2015.3764/2015

Citation tools
Martínez Andrés B, Sastre Lozano V, Sánchez Melgarejo J. Sweet syndrome after treatment with vedolizumab in a patient with Crohn’s disease. 5603/2018


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1044 visits.
This article has been downloaded 347 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 15/03/2018

Accepted: 22/03/2018

Online First: 14/06/2018

Published: 30/07/2018

Article Online First time: 91 days

Article editing time: 137 days


Share
This article has been rated by 2 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology